Munder Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Munder Capital Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$5.34M	Sell	102,789 -10,431	-9%	-$532K	0.04%	290
2014 Q2	$5.81M	Buy	113,220 +46,020	+68%	+$2.07M	0.04%	283
2014 Q1	$3.19M	Buy	+67,200	New	+$3.44M	0.02%	334

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

Munder Capital Management's XBI Position: Q3 2014 in Review

Munder Capital Management reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 9.2% in Q3 2014, selling an estimated $532K and leaving 102,789 shares worth $5.34M. The position accounts for 0.04% of the portfolio, ranked #290.

Munder Capital Management first reported a position in XBI in Q1 2014 and has held it in 3 quarters since. The position peaked at $5.81M in Q2 2014. 129 funds tracked by Wall St. Rank hold XBI as of Q3 2014.

Munder Capital Management held 102,789 shares of State Street SPDR S&P Biotech ETF worth $5.34M as of Q3 2014.
Munder Capital Management sold 10,431 State Street SPDR S&P Biotech ETF shares in Q3 2014, an estimated $532K.
State Street SPDR S&P Biotech ETF made up 0.04% of Munder Capital Management's portfolio in Q3 2014, its #290 holding.
Munder Capital Management first reported a position in State Street SPDR S&P Biotech ETF in Q1 2014 and has held it in 3 quarters since.
Munder Capital Management's State Street SPDR S&P Biotech ETF position peaked at $5.81M in Q2 2014.
129 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2014.

Based on Munder Capital Management's 13F filing for Q3 2014, filed 31 Oct 2014.